查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1497562

病理学人工智慧市场：按组件、神经网路、应用程式和最终用户划分 - 2024-2030 年全球预测

AI in Pathology Market by Component (Hardware, Software), Neural Network (Convolutional neural networks (CNNs), Generative adversarial networks (GANs), Recurrent neural networks (RNNs)), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

病理学人工智慧市场规模预估2023年为2,901万美元，预估2024年将达3,336万美元，2030年将达7,875万美元，复合年增长率为15.33%。

病理学中的人工智慧（AI）透过整合先进的计算技术、机器学习演算法和影像分析工具来自动化诊断过程的各个方面，从而提高病理诊断的速度、准确性和效率。准确快速诊断的新兴市场的开拓、需要及时诊断的癌症等慢性疾病的盛行率不断上升，以及数位病理基础设施的持续发展，都有力地促进了市场的成长。此外，政府也持续投资研发活动和支持性倡议，旨在加速医疗保健数位化。此外，对于许多医疗机构来说，开发和整合基于人工智慧的病理学解决方案可能成本高昂。此外，使用基于云端基础的解决方案共用患者资料会引发对资料外洩和未授权存取敏感资讯的担忧。除此之外，机器学习技术和人工智慧能力的快速进步正在为市场成长创造潜在机会。此外，还可以利用区块链等新技术来确保患者资料的安全储存和传输。

主要市场统计
基准年[2023] 2901万美元
预测年份 [2024] 3336万美元
预测年份 [2030] 7875万美元
复合年增长率（%） 15.33%

区域洞察

在美洲，人工智慧驱动的病理解决方案正在进行大量投资，以推进数位诊断。食品药物管理局也开始批准以人工智慧为基础的医疗设备，显示这些技术正在获得认可。欧盟委员会的计划为专注于健康和护理数位转型的计划提供了大量资金。改善欧盟地区的医疗基础设施为基于人工智慧的病理解决方案提供了独特的机会。在亚太地区，领先的公司正在大力投资数位诊断。政府措施也支持该领域的研究和开发，产生了大量专利和研究出版物。此外，亚太地区新兴经济体医疗保健基础设施的发展正在推动数位医疗保健解决方案的采用。

FPNV定位矩阵

FPNV 定位矩阵对于评估病理学人工智慧市场供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一个综合工具，可以对病理学市场人工智慧供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该领域竞争性质的宝贵见解，包括累积研究期、片段化优势和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在病理学市场人工智慧中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地病理学数位化取得进展
      • 由于慢性病的传播，对远距病理学的需求不断增加
    • 抑制因素
      • 病理学人工智慧相关的高成本
    • 机会
      • 病理学人工智慧的技术进步
      • 对个人化和客製化医疗保健的需求不断增长
    • 任务
      • 资料隐私问题
  • 市场区隔分析
    • 组件：广泛的病理学软体应用程序，可实现无缝工作流程和高效资料管理
    • 神经网路：提高诊断准确性和效率将增加生成对抗网路的采用
    • 应用：广泛利用AI在病理领域进行疾病诊断，促进疾病早期发现
    • 最终用户：在製药和生物技术公司中扩展病理学人工智慧以实现潜在的治疗发现
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章病理学人工智慧市场：按组成部分

  • 硬体
  • 软体

第七章病理学中的人工智慧市场神经网络

  • 卷积类神经网路（CNN）
  • 生成对抗网路（GAN）
  • 循环神经网路 (RNN)

第八章病理学人工智慧市场：按应用分类

  • 临床工作流程
  • 疾病诊断与预后
  • 药物发现
  • 培训和教育

第 9 章病理学人工智慧市场：按最终用户划分

  • 学术研究所
  • 医院
  • 製药和生物技术公司

第 10 章：美洲病理学人工智慧市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区病理学人工智慧市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章：欧洲、中东和非洲病理学人工智慧市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 微软协助打造全球最大的病理学和肿瘤学成像人工智慧
    • PathAI 推出 PathExplore，这是一款由人工智慧驱动的病理学面板，可从肿瘤微环境中解锁开拓的见解
    • Page 和 Leica Biosystems 宣布扩大合作伙伴关係，以加强影像管理和人工智慧技术在全球数位病理工作流程中的使用
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-1730A405FA4B

[189 Pages Report] The AI in Pathology Market size was estimated at USD 29.01 million in 2023 and expected to reach USD 33.36 million in 2024, at a CAGR 15.33% to reach USD 78.75 million by 2030.

Artificial intelligence (AI) in pathology integrates advanced computational techniques, machine learning algorithms, and image analysis tools to improve pathological diagnoses' speed, accuracy, and efficiency by automating various aspects of the diagnostic process. Increasing demand for accurate and quick diagnostics, the rising chronic diseases prevalence such as cancer that require timely diagnosis, and continuous developments in digital pathology infrastructure strongly contribute to the growth of the market. In addition, ongoing investments in research and development activities and supportive government initiatives aimed at promoting healthcare digitization. Furthermore, the development and integration of AI-based solutions in pathology can be an expensive affair for many healthcare organizations. Also, the usage of cloud-based solutions for sharing patient data raises concerns about data breaches and unauthorized access to sensitive information. Apart from this, rapid advancements in machine learning techniques & artificial intelligence capabilities create a potential opportunity for market growth. Additionally, emerging technologies such as blockchain can be leveraged to ensure secure storage and transfer of patient data.

KEY MARKET STATISTICS
Base Year [2023] USD 29.01 million
Estimated Year [2024] USD 33.36 million
Forecast Year [2030] USD 78.75 million
CAGR (%) 15.33%

Regional Insights

In the Americas, significant investments have been made in AI-driven pathology solutions to advance digital diagnostics. The Food and Drug Administration has also started approving AI-based medical devices, demonstrating an increasing acceptance of such technologies. The European Commission's program has provided significant funding for projects focusing on digital transformation in health and care. Improved healthcare infrastructure in the EU region presents a unique opportunity for AI-based pathology solutions. In the APAC region, major players have made significant investments in digital diagnostics. Government initiatives have also supported R&D in this sector, leading to numerous patents and research publications. Also, the development of healthcare infrastructure in the developing economies of the APAC region endorses the adoption of digital healthcare solutions.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the AI in Pathology Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing digitalization of pathology worldwide
      • Growing need for telepathology with the prevalence of chronic disease
    • Market Restraints
      • High cost associated with AI in pathology
    • Market Opportunities
      • Technological advancements in AI in pathology
      • Rising demand for personalized and customized medicine
    • Market Challenges
      • Concerns associated with data privacy
  • Market Segmentation Analysis
    • Component: Extensive software applications in pathology for seamless workflows and efficient data management
    • Neural Network: Increasing generative adversarial networks adoption due to diagnostic accuracy and efficiency
    • Application: Wide utilization of AI in pathology for disease diagnosis to facilitate early detection of diseases
    • End-User: Expansion of pathology AI in pharmaceuticals & biotechnology companies for discovering potential therapeutics
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the AI in Pathology Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the AI in Pathology Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Microsoft Collab to Build World's Largest Pathology, Oncology Imaging AI

Microsoft and healthcare technology company Paige have partnered to create image-based AI models for digital pathology and oncology, with the goal of revolutionizing cancer diagnosis and patient care. Paige has developed an AI model that has been trained on over 1 billion images from half a million pathology slides across various cancer types. This collaboration aims to expand the model to an even larger scale by incorporating up to 4 million digitized microscopy slides. [Published On: 2023-09-07]

PathAI Announces PathExplore, an AI-powered Pathology Panel to Unlock Untapped Insights from the Tumor Microenvironment

PathExplore, powered by artificial intelligence, is a groundbreaking technology that provides single-cell resolution of the tumor microenvironment from H&E whole-slide images. This innovative technology aims to unlock valuable insights into disease states, potentially leading to improved patient outcomes and more targeted oncology therapies. Unlike current technologies, PathExplore offers a unique combination of deep resolution and scalability, making it suitable for analyzing massive numbers of patient samples. [Published On: 2023-04-04]

Paige and Leica Biosystems Announce Expanded Partnership to Enhance Use of Image Management and Artificial Intelligence Technology in Global Digital Pathology Workflows

Paige and Leica Biosystems have announced an expanded partnership to enhance the utilization of digital pathology workflows. As part of this collaboration, a co-branded version of Paige's Platform was introduced, serving as the central interface connecting pathologists with Leica Biosystems hardware. This partnership provides users of Aperio GT 450 scanners with comprehensive access to Paige's suite of digital pathology software, encompassing the FullFocus viewer, the AI-powered worklist FullFolio, and a range of other AI software solutions. [Published On: 2023-03-12]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the AI in Pathology Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the AI in Pathology Market, highlighting leading vendors and their innovative profiles. These include aetherAI, Aiforia Technologies Oyj, Akoya Biosciences, Inc., Deep Bio, Inc., Evident Corporation, F. Hoffmann-La Roche Ltd., Ibex Medical Analytics Ltd., Indica Labs, Inc., Inspirata, Inc., LUMEA, Inc., MindPeak GmbH, Nucleai Inc., OptraSCAN Inc., Paige.AI, Inc., PathAI, Inc., Proscia Inc., Techcyte, Inc., Tempus Labs, Inc., Tribun Health, Visikol, Inc. by CELLINK, and Visiopharm A/S.

Market Segmentation & Coverage

This research report categorizes the AI in Pathology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Component
    • Hardware
    • Software
  • Neural Network
    • Convolutional neural networks (CNNs)
    • Generative adversarial networks (GANs)
    • Recurrent neural networks (RNNs)
  • Application
    • Clinical Workflow
    • Disease Diagnosis & Prognosis
    • Drug Discovery
    • Training & Education
  • End-User
    • Academic & Research Institutes
    • Hospitals
    • Pharmaceuticals & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing digitalization of pathology worldwide
      • 5.1.1.2. Growing need for telepathology with the prevalence of chronic disease
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with AI in pathology
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in AI in pathology
      • 5.1.3.2. Rising demand for personalized and customized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with data privacy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Extensive software applications in pathology for seamless workflows and efficient data management
    • 5.2.2. Neural Network: Increasing generative adversarial networks adoption due to diagnostic accuracy and efficiency
    • 5.2.3. Application: Wide utilization of AI in pathology for disease diagnosis to facilitate early detection of diseases
    • 5.2.4. End-User: Expansion of pathology AI in pharmaceuticals & biotechnology companies for discovering potential therapeutics
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. AI in Pathology Market, by Component

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Software

7. AI in Pathology Market, by Neural Network

  • 7.1. Introduction
  • 7.2. Convolutional neural networks (CNNs)
  • 7.3. Generative adversarial networks (GANs)
  • 7.4. Recurrent neural networks (RNNs)

8. AI in Pathology Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Workflow
  • 8.3. Disease Diagnosis & Prognosis
  • 8.4. Drug Discovery
  • 8.5. Training & Education

9. AI in Pathology Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals
  • 9.4. Pharmaceuticals & Biotechnology Companies

10. Americas AI in Pathology Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific AI in Pathology Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa AI in Pathology Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Microsoft Collab to Build World's Largest Pathology, Oncology Imaging AI
    • 13.3.2. PathAI Announces PathExplore, an AI-powered Pathology Panel to Unlock Untapped Insights from the Tumor Microenvironment
    • 13.3.3. Paige and Leica Biosystems Announce Expanded Partnership to Enhance Use of Image Management and Artificial Intelligence Technology in Global Digital Pathology Workflows
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. AI IN PATHOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. AI IN PATHOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AI IN PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. AI IN PATHOLOGY MARKET DYNAMICS
  • FIGURE 7. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. AI IN PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. AI IN PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AI IN PATHOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AI IN PATHOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL AI IN PATHOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS (CNNS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS (CNNS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS (GANS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY GENERATIVE ADVERSARIAL NETWORKS (GANS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY RECURRENT NEURAL NETWORKS (RNNS), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY RECURRENT NEURAL NETWORKS (RNNS), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CLINICAL WORKFLOW, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY CLINICAL WORKFLOW, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS & PROGNOSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DISEASE DIAGNOSIS & PROGNOSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL AI IN PATHOLOGY MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 59. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 60. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 61. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. CANADA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 66. CANADA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 67. CANADA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 68. CANADA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 69. CANADA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. CANADA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. CANADA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. CANADA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. MEXICO AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 74. MEXICO AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 75. MEXICO AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 76. MEXICO AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 77. MEXICO AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. MEXICO AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. MEXICO AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. MEXICO AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 82. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 83. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 84. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 85. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 90. UNITED STATES AI IN PATHOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 102. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 104. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 105. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. AUSTRALIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. CHINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 110. CHINA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 111. CHINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 112. CHINA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 113. CHINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. CHINA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. CHINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. CHINA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. INDIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 118. INDIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 119. INDIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 120. INDIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 121. INDIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. INDIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. INDIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. INDIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 126. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 127. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 128. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 129. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 132. INDONESIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 133. JAPAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 134. JAPAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 135. JAPAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 136. JAPAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 137. JAPAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. JAPAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. JAPAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. JAPAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 142. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 143. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 144. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 145. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. MALAYSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 150. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 151. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 152. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 153. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. PHILIPPINES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 158. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 159. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 160. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 161. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. SINGAPORE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 167. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 168. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH KOREA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 174. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 175. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 176. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 177. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. TAIWAN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. THAILAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 182. THAILAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 183. THAILAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 184. THAILAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 185. THAILAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. THAILAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. THAILAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 188. THAILAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 189. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 190. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 191. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 192. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 193. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. VIETNAM AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA AI IN PATHOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 207. DENMARK AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 208. DENMARK AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 209. DENMARK AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 210. DENMARK AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 211. DENMARK AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. DENMARK AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. DENMARK AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. DENMARK AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. EGYPT AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 216. EGYPT AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 217. EGYPT AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 218. EGYPT AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 219. EGYPT AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. EGYPT AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. EGYPT AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. EGYPT AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. FINLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 224. FINLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 225. FINLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 226. FINLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 227. FINLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. FINLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. FINLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. FINLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. FRANCE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 232. FRANCE AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 233. FRANCE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 234. FRANCE AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 235. FRANCE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. FRANCE AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. FRANCE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 238. FRANCE AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 239. GERMANY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 240. GERMANY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 241. GERMANY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 242. GERMANY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 243. GERMANY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. GERMANY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. GERMANY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. GERMANY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 248. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 249. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 250. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 251. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. ISRAEL AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. ITALY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 256. ITALY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 257. ITALY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 258. ITALY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 259. ITALY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. ITALY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. ITALY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. ITALY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 264. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 265. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 266. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 267. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. NETHERLANDS AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 272. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 273. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 274. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 275. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. NIGERIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. NORWAY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 280. NORWAY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 281. NORWAY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 282. NORWAY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 283. NORWAY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. NORWAY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. NORWAY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 286. NORWAY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 287. POLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 288. POLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 289. POLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 290. POLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 291. POLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. POLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. POLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 294. POLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 295. QATAR AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 296. QATAR AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 297. QATAR AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 298. QATAR AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 299. QATAR AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. QATAR AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. QATAR AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 302. QATAR AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 303. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 304. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 305. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 306. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 307. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 310. RUSSIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 311. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 312. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 313. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 314. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 315. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. SAUDI ARABIA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 320. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 321. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 322. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 323. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 324. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 325. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 326. SOUTH AFRICA AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 327. SPAIN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 328. SPAIN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 329. SPAIN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 330. SPAIN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 331. SPAIN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 332. SPAIN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 333. SPAIN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 334. SPAIN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 335. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 336. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 337. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 338. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 339. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 342. SWEDEN AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 343. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 344. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 345. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 346. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 347. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 349. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 350. SWITZERLAND AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 351. TURKEY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 352. TURKEY AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 353. TURKEY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 354. TURKEY AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 355. TURKEY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 356. TURKEY AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 357. TURKEY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 358. TURKEY AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 359. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2018-2023 (USD MILLION)
  • TABLE 360. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY COMPONENT, 2024-2030 (USD MILLION)
  • TABLE 361. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2018-2023 (USD MILLION)
  • TABLE 362. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY NEURAL NETWORK, 2024-2030 (USD MILLION)
  • TABLE 363. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 364. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 365. UNITED ARAB EMIRATES AI IN PATHOLOGY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 366. UNITE